Percutaneous pulmonary valve replacement: autologous tissue-engineered valved stents.

AIMS Percutaneous implantation has already been used clinically and is a great option for treating young patients. The use of autologous tissue-engineered valved stents might solve the problem of degeneration and limited durability of biological heart valves. METHODS AND RESULTS Porcine pulmonary heart valves and small intestinal submucosa were obtained from a slaughterhouse. The intestinal submucosa was used to cover the inside of the porcine pulmonary valved stents. Endothelial cells (ECs) and autologous myofibroblasts (MFs) were used from carotid artery segments of juvenile sheep. After MF seeding, constructs were placed in a dynamic bioreactor system and cultured for 16 days. After additional EC seeding, tissue-engineered valved stents were percutaneously deployed into the annulus of the pulmonary valve (n = 9). Angiography was performed at implantation and 4-week follow-up. Constructs were analysed radiographically, by post-mortem examination, and microscopically. In all but one case, orthotopic positioning of the stents (n = 6) at the time of implantation and explantation was observed angiographically, macroscopically, and by computer tomography scan and demonstrated normal valve function (n = 7). Gross morphology confirmed excellent opening and closure characteristics of all leaflets after 4 weeks (n = 7). Strong expression of α-smooth muscle actin in neo-interstitial cells and of von Willebrand factor and PECAM-1 in ECs was revealed by immunocytochemistry. CONCLUSION Good functioning and morphological characteristics were observed after percutaneous tissue-engineered valved stent implantation with autologous cells. This implantation of autologous tissue-engineered valved stents will become a valid future option in adolescents.

[1]  R A Good,et al.  Cellular engineering. , 1977, Clinical bulletin.

[2]  J Kachaner,et al.  Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. , 2000, Circulation.

[3]  L. Lambert,et al.  Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. , 2000, The Journal of thoracic and cardiovascular surgery.

[4]  P. Bonhoeffer,et al.  Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction , 2000, The Lancet.

[5]  J M Gross,et al.  Calcification of bioprosthetic heart valves and its assessment. , 2001, The Journal of thoracic and cardiovascular surgery.

[6]  E Wolner,et al.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  H. Schaff,et al.  Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. , 2003, The Annals of thoracic surgery.

[8]  K J Halbhuber,et al.  Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. , 2003, Cardiovascular research.

[9]  K J Halbhuber,et al.  Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[10]  B. Eyskens,et al.  The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. , 2005, The Journal of thoracic and cardiovascular surgery.

[11]  A. Redington,et al.  Pulmonary Regurgitation Is an Important Determinant of Right Ventricular Contractile Dysfunction in Patients With Surgically Repaired Tetralogy of Fallot , 2004, Circulation.

[12]  A. Hofman,et al.  Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly , 2005, Circulation.

[13]  W. Konertz,et al.  Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  Ernst Wolner,et al.  Tissue Engineering of Heart Valves: Decellularized Porcine and Human Valve Scaffolds Differ Importantly in Residual Potential to Attract Monocytic Cells , 2005, Circulation.

[15]  A. Boening,et al.  Advances in experimental percutaneous pulmonary valve replacement. , 2005, The Annals of thoracic surgery.

[16]  Artur Lichtenberg,et al.  Preclinical Testing of Tissue-Engineered Heart Valves Re-Endothelialized Under Simulated Physiological Conditions , 2006, Circulation.

[17]  U. Stock,et al.  Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves. , 2006, The Journal of thoracic and cardiovascular surgery.

[18]  Artur Lichtenberg,et al.  Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells , 2006, Circulation.

[19]  A. Lichtenberg,et al.  Tissue engineered heart valves re-endothelialized under simulated physiological conditions: Preclinical testing , 2006 .

[20]  A. Boening,et al.  Percutaneous pulmonary valve replacement: 3-month evaluation of self-expanding valved stents. , 2006, The Annals of thoracic surgery.

[21]  F. Migliavacca,et al.  Percutaneous pulmonary valve implantation based on rapid prototyping of right ventricular outflow tract and pulmonary trunk from MR data. , 2007, Radiology.

[22]  James D. Thomas,et al.  3D echocardiography: a review of the current status and future directions. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  D. Shcherbo,et al.  Bright far-red fluorescent protein for whole-body imaging , 2007, Nature Methods.

[24]  Vivek Muthurangu,et al.  Percutaneous Pulmonary Valve Implantation: Impact of Evolving Technology and Learning Curve on Clinical Outcome , 2008, Circulation.

[25]  U. Stock,et al.  In vivo tissue engineering of heart valves: evolution of a novel concept. , 2009, Regenerative medicine.

[26]  G. Gerosa,et al.  The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. , 2009, Biomaterials.

[27]  S. Dittrich,et al.  Early failure of xenogenous de-cellularised pulmonary valve conduits--a word of caution! , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  Ming Li,et al.  Midterm results of transapical aortic valve replacement via real-time magnetic resonance imaging guidance. , 2010, The Journal of thoracic and cardiovascular surgery.

[29]  A. Taylor,et al.  First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[30]  U. Steinseifer,et al.  Percutaneous pulmonary polyurethane valved stent implantation. , 2010, The Journal of thoracic and cardiovascular surgery.